Heritage Pharma sues over container of refrigerated drugs knocked into river

Generics maker Heritage Pharmaceuticals has filed a federal lawsuit after a supply chain mishap involving a crane at the Port of Norfolk, Virginia, that dunked a container of drugs into a river. (Norfolk International Ports)

A refrigerated container of drugs was rolling on the river last year when a supply chain mishap resulted in eight shipping containers falling like dominoes from a ship into the Elizabeth River in Virginia. Now Heritage Pharmaceuticals wants reimbursement.

The Eatontown, New Jersey-based drugmaker has filed a federal lawsuit in the Eastern District of Virginia seeking $220,000. The lawsuit names logistics Agility Logistics, Hapag-Lloyd America and Virginia International Terminals.

RELATED: Ex-Heritage execs turn state's evidence in far-reaching generic pricing probe

Webinar This Week

OTC Innovation to Avoid Stagnation: Survey Insights, Expert Advice, and Latest Technologies to Boost Your Product’s Performance

Join us for a complimentary webinar on November 13 at 11am ET / 8am PT. Listen to industry experts as they analyze the critical role of innovation in OTC products, and strategies for achieving it.

The drugmaker says it was moving 562 packages of pharmaceuticals in a refrigerated container, including diabetes meds Glipizide and Metformin. They were in a container on a ship that arrived in the Norfolk port from India in July 2018. The Virginian-Pilot reported last year that the incident occurred when a spreader bar from the crane hit several containers and then eight containers toppled "like dominoes" into the water. The suit says the drugs were a complete loss.

Heritage itself figures prominently in an investigation by states and the Justice Department into alleged pricing fixing of generic drug prices. In 2017, Heritage Pharma’s former CEO Jeffrey Glazer and former president Jason Malek reached settlements to pay $25,000 and cooperate with the ongoing investigation, which has roped in some of the biggest names in the generics business.

In January, UnitedHealthcare leveraged the work done by the states to file a 355-page lawsuit that names dozens of drugmakers for colluding on drug prices.

Suggested Articles

Mylan and Pfizer's Upjohn have a name for their pending merger: Viatris. Heard that before? So has Mylan, which owns a subsidiary with the same name.

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.